Concepedia
Statistics
Publications
10
Citations
1.9K
H-Index
Active since
2017
Affiliations
The Netherlands Cancer Institute(Current)
Radboud University Nijmegen
Radboud University Medical Center
Oncode Institute
University of Lucerne
Robert D. Schouten is an author at The Netherlands Cancer Institute specializing in oncology, cancer immunotherapy, and medicine.
Publications per year
2017–2022
Immune checkpoint inhibitors for patients with advanced lung cancer and oncogenic driver alterations: results from the IMMUNOTARGET registry
J. Mazieres, Alexander Drilon, Amélie Lusque et al. · Annals of Oncology · 2019 · 1.4K citations · Full text
Life Sciences, Immunology, Oncology +17
Programmed Death 1 Blockade With Nivolumab in Patients With Recurrent Malignant Pleural Mesothelioma
Josine M.M.F. Quispel-Janssen, Vincent van der Noort, Jeltje F. de Vries et al. · Journal of Thoracic Oncology · 2018 · 251 citations · Full text
Medicine, Oncology, Pharmacology +17
Prediction of response to anti-PD-1 therapy in patients with non-small-cell lung cancer by electronic nose analysis of exhaled breath
R. de Vries, Mirte Muller, Vincent van der Noort et al. · Annals of Oncology · 2019 · 78 citations · Full text
Medicine, Immunology, Oncology +17
Efficacy of immune-checkpoint inhibitors (ICI) in non-small cell lung cancer (NSCLC) patients harboring activating molecular alterations (ImmunoTarget).
Julien Mazieres, Alexander Drilon, Laurent Mhanna et al. · Journal of Clinical Oncology · 2018 · 54 citations
OA13.01 A Phase II Study of Nivolumab in Malignant Pleural Mesothelioma (NivoMes): with Translational Research (TR) Biopies
Josine M.M.F. Quispel-Janssen, Giulia Zago, Robert D. Schouten et al. · Journal of Thoracic Oncology · 2017 · 53 citations · Full text
Medicine, Oncology, Pharmacology +16
1–5 of 10